Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
Arcus Biosciences priced an underwritten public offering of 14,285,715 shares at $17.50 per share for expected gross proceeds of $250.0 million. Underwriters hold a 30-day option on up to 2,142,857 additional shares, and the offering is expected to close on October 23, 2026.
Key figures
- Deal Value Usd
- 250000000
- Offering Price
- 17.5
- Shares Offered
- 14285715
- Underwriter option shares
- 2142857
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.